Evidence map›Paper›PMID 30118343›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2018

Mineralocorticoid receptor antagonism improves parenchymal arteriole dilation via a TRPV4-dependent mechanism and prevents cognitive dysfunction in hypertension.

Janice M Diaz-Otero, Ting-Chieh Yen, Courtney Fisher, Daniel Bota, William F Jackson, Anne M Dorrance

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Current updates on latest basic research of scientific relevance in hypertensive dementia.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Immune system activation and cognitive impairment in arterial hypertension.American journal of physiology. Cell physiology · 2024
    Review
  9. Review
  10. Review
  11. Neurosteroid Receptor Modulators for Treating Traumatic Brain Injury.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Review
  12. Article
  13. Review
  14. Review
  15. Cerebral arteriolar and neurovascular dysfunction after chemically induced menopause in mice.American journal of physiology. Heart and circulatory physiology · 2022
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Janice M Diaz-OteroDepartment of Pharmacology and Toxicology, Michigan State University , East Lansing, Michigan.ORCID 0000-0003-2099-2089
Ting-Chieh YenDepartment of Pharmacology and Toxicology, Michigan State University , East Lansing, Michigan.
Courtney FisherDepartment of Pharmacology and Toxicology, Michigan State University , East Lansing, Michigan.
Daniel BotaDepartment of Pharmacology and Toxicology, Michigan State University , East Lansing, Michigan.
William F JacksonDepartment of Pharmacology and Toxicology, Michigan State University , East Lansing, Michigan.ORCID 0000-0002-9657-0141
Anne M DorranceDepartment of Pharmacology and Toxicology, Michigan State University , East Lansing, Michigan.
Michigan State University · US

Funding

SIGNALING MECHANISMS IN ARTERIES AND VEINS IN HYPERTENSIONP01HL070687 · NHLBI · MICHIGAN STATE UNIVERSITY · PI FINK, GREGORY D · 2003 to 2019
$22.8M
Cerebral parenchymal arteriole dysfunction and cognitive decline in a life-long high fat feeding modelR01HL137694 · NHLBI · MICHIGAN STATE UNIVERSITY · PI DORRANCE, ANNE M., JACKSON, WILLIAM F. · 2017 to 2020
$2.1M
Integrative Training in the Pharmacological SciencesT32GM092715 · NIGMS · MICHIGAN STATE UNIVERSITY · PI NEUBIG, RICHARD R · 2011 to 2020
$1.5M
The effects of endothelial mineralocorticoid receptors in cerebral artery remodeling and endothelial injuryF31NS090866 · NINDS · MICHIGAN STATE UNIVERSITY · PI DIAZ-OTERO, JANICE MARIE · 2017 to 2018
$82k
NHLBI NIH HHS P01 HL070687NHLBI NIH HHS R01 HL137694NIGMS NIH HHS T32 GM092715NINDS NIH HHS F31 NS090866
6 · The paper itself

Abstract

Hypertension and mineralocorticoid receptor activation cause cerebral parenchymal arteriole remodeling; this can limit cerebral perfusion and contribute to cognitive dysfunction. We used a mouse model of angiotensin II-induced hypertension to test the hypothesis that mineralocorticoid receptor activation impairs both transient receptor potential vanilloid (TRPV)4-mediated dilation of cerebral parenchymal arterioles and cognitive function. Mice (16-18 wk old, male, C57Bl/6) were treated with angiotensin II (800 ng·kg

Indexed as

Angiotensin IIAnimalsAntihypertensive AgentsArteriolesBehavior, AnimalBrainCognitionCognition DisordersDisease Models, AnimalEplerenoneHypertensionMaleMaze LearningMice, Inbred C57BLMineralocorticoid Receptor AntagonistsNesting BehaviorAngiotensin IIAntihypertensive AgentsEplerenoneMineralocorticoid Receptor AntagonistsTrpv4 protein, mouseTRPV Cation Channelsaldosteroneendotheliumhypertensionmicrocirculationtransient receptor potential vanilloid 4 channelsvasculature

Identifiers

PMID30118343
PMCPMC6297805
OpenAlexW2887478437

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.